Ab­b­Vie pulls the trig­ger on a Covid-19 an­ti­body, go­ing all in on a drug dis­cov­ered by re­search al­liance

With mul­ti­ple re­pur­posed Covid-19 treat­ments al­ready in the clin­ic (and one that flunked out), Ab­b­Vie is plac­ing its next bet on some­thing new: an ex­per­i­men­tal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER